Sorrento planning pain spinout

Sorrento Therapeutics Inc. (NASDAQ:SRNE) plans to spin out its Scintilla Pharmaceuticals Inc. subsidiary as an independent company focused on pain management. The separation is due to

Read the full 263 word article

How to gain access

Continue reading with a
two-week free trial.